Novocure's device shown to slow cancer progression in the brain in trial
Go back to Novocure's device shown to slow cancer progression in the brain in trial| (NASDAQ: NVCR) | Delayed: 12.90 -0.21 (1.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.11 | 52 Week High | $28.95 | |||
| Open | $12.81 | 52 Week Low | $5.95 | |||
| Day High | $13.00 | P/E | N/A | |||
| Day Low | $12.52 | EPS | $0.00 | |||
| Volume | 262,738 | |||||



